BPA

International Formula Council Statement on Bisphenol A (BPA)

The infant formula industry takes all potential safety concerns very seriously, and we support science-based efforts to produce infant formula products of the highest possible quality.  When new information becomes available on substances like BPA, we support bringing that information forward through the accepted process of scientific peer review and evaluation. 

BPA and Babies: New Research From FDA Focuses On What Happens In Womb

Forbes.com writer, Trevor Butterworth, looks at the bisphenol A (BPA) debate and finds that many media outlets neglect the complex studies coming out of regulatory agencies in favor of less scientific, overly simplistic studies advancing alarming health claims. He says “Not all scientific studies are created equal.” Butterworth interviews Daniel R.

FDA Publishes Survey of BPA and Infant Formula

International Formula Council Statement on FDA Survey of BPA and Infant Formula

The International Formula Council* (IFC) supports the U.S.

BPA and Liquid Infant Formula Packaging

International Formula Council Statement on BPA and Liquid Infant Formula Packaging

On January 15, the U.S.

BPA in Premature Infants

Study Examining BPA Exposure in Premature Infants by Calfat et al.

A study by Calfat et al. published in the January 2009 edition of Environmental Health Perspectives describes a cross-sectional study in which urine samples from premature infants in two Boston-area hospitals were analyzed for free and total BPA and other compounds.1 This critique will focus only on the results pertaining to BPA. A total of 41 infants had at least one urine sample available for analysis of BPA and the authors were able to analyze both free and total BPA in 37 infants.

BPA Toxicokinetics

IFC Comments on Recent Mathematical Modeling study of BPA Toxicokinetics by Edginton and Ritter

Edington and Ritter present a mathematical model of the toxicokinetics of BPA and its glucuronidated metabolite, BPA-Glu, and estimate that the average steady state BPA plasma concentration in newborns is eleven times that in adults, when given the same weight-normalized dose.1  Additionally, they estimate by simulating typical feeding exposures, infants 3 and 6 months old show a five times greater steady state BPA plasma concentration when compared to adults. 

Infant Formula Safe and Healthy

Infant Formula Industry Reassures Parents that Infant Formulas Meet the Highest Safety Standards of Any Food Product on the Market

Testimony at FDA Science Board Hearing on BPA Reiterates Industry's Ongoing Commitment to Working with Regulatory Authorities to Protect the Health and Safety of Infants

WASHINGTON (Oct. 31, 2008) – The International Formula Council (IFC)*, testifying today along with other interested parties at the FDA Science Board meeting, expressed the infant formula industry’s support of science-based efforts to continually ensure that infant formulas meet the highest safety standards of any food product on the market.

FDA Science Board and BPA

IFC Statement on FDA Science Board Subcommittee Report on Bisphenol A (BPA)

A subcommittee of the Food and Drug Administration (FDA) Science Board recently reviewed the FDA’s safety assessment for Bisphenol A (BPA).  The Subcommittee made recommendations for the Science Board to consider, as part of the standard multi-step scientific review process for establishing a sound risk assessment based on well-defined criteria.

BPA and Breast Cancer

IFC Evaluation of Study on Bisphenol A and Chemoresistance in Breast Cancer Cells

A study published in the October 2008 edition of Environmental Health Perspectives titled, “Bisphenol A at Low Nanomolar Doses Confers Chemoresistance in Estrogen Receptor Alpha Positive and Negative Breast Cancer Cells”1 found that 24 hour pretreatment of cells with free Bisphenol A (BPA) increased the chemoresistance of two breast cancer cell lines in vitro.  This study, however, has some major limitations which reduce the applicability of its findings.

The study was